The Need and Importance of Incorporating Academic Research Results in to the Curricula of Ayurveda in India.

Samal, Janmejaya; Dehury, Ranjit Kumar

doi:10.7860/jcdr/2017/26742.10112

Cited by 4 publications

(4 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Utilization of modern research tools in such instances can help identify toxic components and beneficial compounds for multiple disease conditions. Much of current CAM-based research studies are of poor quality, inclusive of paltry hypotheses, suffering from inadequate methodology, meddled with impecunious statistical analysis, and ultimately lost to predatory or low-grade nonindexed journals, being further showcased as clinical data to an unknowing patient population for better for-profit sale of the product 54,55. A prime example is of the Ayurvedic antimalarial drug AYUSH-64, on which a non-controlled clinical trial was published (in the year 1981; without ethical statements and disclosures; alarmingly showcasing complete confidential patient details in Table 1 of the published study) in a journal ( Journal of Research in Ayurveda and Siddha , Vol 2, No 4, pages 309–26), which is currently not traceable to any valid scientific data indexing repositories.…”

Section: Current Perspectives and Future Directionsmentioning

confidence: 99%

Complementary and Alternative Medicine-related Drug-induced Liver Injury in Asia

Philips¹,

Augustine²,

Rajesh³

et al. 2019

Journal of Clinical and Translational Hepatology

View full text Add to dashboard Cite

The use of complementary and alternative medicines (CAMs) for treatment of acute and chronic diseases is on the rise world over, especially in Asian countries, and mostly in China and India. Drug-induced liver injury (DILI) due to CAM is increasingly reported in the literature from multiple centers all around the world and with large-number patient series published from the West, mostly based on nation-wide DILI networks and multicenter collaboration. Comprehensive DILI networks are lacking among major Asian countries with high incidence of CAM practices. Chinese medical societies dealing with drug toxicity, CAM practice and hepatobiliary disease have adopted an integrated approach to establishing identification, diagnosis and treatment of CAM-related DILI, representing a systematic approach that could be iterated by other countries for improving patient outcomes. In this exhaustive review, we provide published data on CAM-related DILI in Asia, with detail on incidences along with analysis of patient population and their clinical outcomes. Concise and clear discussion on commonly implicated CAM agents in major Asian countries and associated chemical and toxicology analyses as well as descriptions of liver biopsy findings are discussed with future directions.

show abstract

Section: Current Perspectives and Future Directionsmentioning

confidence: 99%

Complementary and Alternative Medicine-related Drug-induced Liver Injury in Asia

Philips¹,

Augustine²,

Rajesh³

et al. 2019

Journal of Clinical and Translational Hepatology

View full text Add to dashboard Cite

show abstract

“…A number of studies focused on the issue at the national level in countries such as Brazil (Perlin, Imasato, & Borenstein, 2018), the Czech Republic (Mercier, Tardif, et al, 2018;Strielkowski, Gryshova, & Shcherbata, 2017;Vershinina, Tarasova, & Strielkowski, 2017), Iran (Erfanmanesh & Pourhossein, 2017), India (Mukherjee, 2018;Samal & Dehury, 2017;Seethapathy, Kumar, & Hareesha, 2016), Turkey (Demir, 2018a, b;Onder & Erdil, 2017), and Kazakhstan (Yessirkepov, Nurmashev, & Anartayeva, 2015).…”

Section: Results In Relation To Other Studiesmentioning

confidence: 99%

Methodological considerations for identifying questionable publishing in a national context: The case of Swedish Higher Education Institutions

Nelhans

Bodin

2020

Quantitative Science Studies

View full text Add to dashboard Cite

The overall scope of this study is an attempt at a methodological framework for matching publication lists at the national level against a combined set of blacklists for questionable publishing. Using the total verified set of publications from Swedish Higher Education Institutions (HEI) as a case, we examined the number, distribution, and proportion of publishing in questionable journals at the national level. Journal publication data was extracted from the national SwePub database and matched against three curated blacklists of questionable publishing. For the period 2012–2017, we identified 1,743 published papers in blacklisted journals, equal to an average of 0.5–0.9% of the total publications from Swedish HEIs. There was high variability between different HEI categories, with more established universities at the lower end of the spectrum, while university colleges and new universities had a much higher proportion (∼2%). There was a general decreasing trend during the study period (ρ = 0.83) for all categories of HEIs. The study presents a methodology to identify questionable publishing in academia that could be applied to other countries with similar infrastructure. Thus, it could serve as a starting point for the development of a general framework for cross-national quantitative estimation of questionable publishing.

show abstract

“…They prescribe many non-evidence-based Ayurvedic medicines, which can have serious adverse effects on individuals, including heavy metal poisoning ( 19 ). They often follow claims made by peers or opt for an approach like “trial and error” ( 18 , 20 ). One of the key hurdles highlighted by them is the lack of a good quality T2DM clinical guideline that can assist their clinical decision-making process and delivery of high-quality care to individuals ( 18 ).…”

Section: Introductionmentioning

confidence: 99%

Development process of a clinical guideline to manage type 2 diabetes in adults by Ayurvedic practitioners

et al. 2023

View full text Add to dashboard Cite

BackgroundType 2 diabetes mellitus (T2DM), a common chronic health condition, has major health and socioeconomic consequences. In the Indian subcontinent, it is a health condition for which individuals commonly consult Ayurvedic (traditional medical system) practitioners and use their medicines. However, to date, a good quality T2DM clinical guideline for Ayurvedic practitioners, grounded on the best available scientific evidence, is not available. Therefore, the study aimed to systematically develop a clinical guideline for Ayurvedic practitioners to manage T2DM in adults.MethodsThe development work was guided by the UK’s National Institute for Health and Care Excellence (NICE) manual for developing guidelines, the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach, and the Appraisal of Guidelines for Research and Evaluation (AGREE) II instrument. First, a comprehensive systematic review was conducted which evaluated Ayurvedic medicines’ effectiveness and safety in managing T2DM. In addition, the GRADE approach was used for assessing the certainty of the findings. Next, using the GRADE approach, the Evidence-to-Decision framework was developed, and we focused on glycemic control and adverse events. Subsequently, based on the Evidence-to-Decision framework, a Guideline Development Group of 17 international members made recommendations on Ayurvedic medicines’ effectiveness and safety in T2DM. These recommendations formed the basis of the clinical guideline, and additional generic content and recommendations were adapted from the T2DM Clinical Knowledge Summaries of the Clarity Informatics (UK). The feedback given by the Guideline Development Group on the draft version was used to amend and finalize the clinical guideline.ResultsA clinical guideline for managing T2DM in adults by Ayurvedic practitioners was developed, which focuses on how practitioners can provide appropriate care, education, and support for people with T2DM (and their carers and family). The clinical guideline provides information on T2DM, such as its definition, risk factors, prevalence, prognosis, and complications; how it should be diagnosed and managed through lifestyle changes like diet and physical activity and Ayurvedic medicines; how the acute and chronic complications of T2DM should be detected and managed (including referral to specialists); and advice on topics like driving, work, and fasting including during religious/socio-cultural festivals.ConclusionWe systematically developed a clinical guideline for Ayurvedic practitioners to manage T2DM in adults.

show abstract

The Need and Importance of Incorporating Academic Research Results in to the Curricula of Ayurveda in India.

Cited by 4 publications

References 4 publications

Complementary and Alternative Medicine-related Drug-induced Liver Injury in Asia

Complementary and Alternative Medicine-related Drug-induced Liver Injury in Asia

Methodological considerations for identifying questionable publishing in a national context: The case of Swedish Higher Education Institutions

Development process of a clinical guideline to manage type 2 diabetes in adults by Ayurvedic practitioners

Contact Info

Product

Resources

About